Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota.

Chadchan SB, Cheng M, Parnell LA, Yin Y, Schriefer A, Mysorekar IU, Kommagani R.

Hum Reprod. 2019 Jun 4;34(6):1106-1116. doi: 10.1093/humrep/dez041.

PMID:
31037294
2.

Investigation of the pathways related to intrinsic miltefosine tolerance in Leishmania (Viannia) braziliensis clinical isolates reveals differences in drug uptake.

Espada CR, Magalhães RM, Cruz MC, Machado PR, Schriefer A, Carvalho EM, Hornillos V, Alves JM, Cruz AK, Coelho AC, Uliana SRB.

Int J Parasitol Drugs Drug Resist. 2019 Feb 25. pii: S2211-3207(18)30168-4. doi: 10.1016/j.ijpddr.2019.02.005. [Epub ahead of print]

3.

Early Suppression of Macrophage Gene Expression by Leishmania braziliensis.

Sousa R, Andrade VM, Bair T, Ettinger NA, Guimarães L, Andrade L, Guimarães LH, Machado PRL, Carvalho EM, Wilson ME, Schriefer A.

Front Microbiol. 2018 Oct 15;9:2464. doi: 10.3389/fmicb.2018.02464. eCollection 2018.

4.

A multi-amplicon 16S rRNA sequencing and analysis method for improved taxonomic profiling of bacterial communities.

Schriefer AE, Cliften PF, Hibberd MC, Sawyer C, Brown-Kennerly V, Burcea L, Klotz E, Crosby SD, Gordon JI, Head RD.

J Microbiol Methods. 2018 Nov;154:6-13. doi: 10.1016/j.mimet.2018.09.019. Epub 2018 Sep 29.

PMID:
30273610
5.

The Elderly Respond to Antimony Therapy for Cutaneous Leishmaniasis Similarly to Young Patients but Have Severe Adverse Reactions.

Lago ASD, Nascimento M, Carvalho AM, Lago N, Silva J, Queiroz JR, Carvalho LP, Schriefer A, Wilson M, Machado P, Carvalho EM.

Am J Trop Med Hyg. 2018 May;98(5):1317-1324. doi: 10.4269/ajtmh.17-0736. Epub 2018 Mar 22.

6.

Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy.

Costa RS, Carvalho LP, Campos TM, Magalhães AS, Passos ST, Schriefer A, Silva JA, Lago E, Paixão CS, Machado P, Scott P, Carvalho EM.

J Infect Dis. 2018 Feb 14;217(5):840-850. doi: 10.1093/infdis/jix627.

7.

Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation.

Halstead AM, Kapadia CD, Bolzenius J, Chu CE, Schriefer A, Wartman LD, Bowman GR, Arora VK.

Elife. 2017 Nov 16;6. pii: e30862. doi: 10.7554/eLife.30862.

8.

Dynamics of American tegumentary leishmaniasis in a highly endemic region for Leishmania (Viannia) braziliensis infection in northeast Brazil.

Silva J, Queiroz A, Moura I, Sousa RS, Guimarães LH, Machado PRL, Lessa M, Lago E, Wilson ME, Schriefer A.

PLoS Negl Trop Dis. 2017 Nov 2;11(11):e0006015. doi: 10.1371/journal.pntd.0006015. eCollection 2017 Nov.

9.

Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.

Silva SC, Guimarães LH, Silva JA, Magalhães V, Medina L, Queiroz A, Machado PRL, Schriefer A.

Acta Trop. 2018 Feb;178:34-39. doi: 10.1016/j.actatropica.2017.10.010. Epub 2017 Oct 16.

10.

Oral Pentoxifylline Associated with Pentavalent Antimony: A Randomized Trial for Cutaneous Leishmaniasis.

Brito G, Dourado M, Guimarães LH, Meireles E, Schriefer A, de Carvalho EM, Machado PRL.

Am J Trop Med Hyg. 2017 May;96(5):1155-1159. doi: 10.4269/ajtmh.16-0435.

11.

Severe and late complication of central venous catheters in a patient with haemophilia A.

da Silveira EO, da Costa Salina TD, Aguiar RD, Schriefer A, Fraiji NA.

Haemophilia. 2017 Mar;23(2):e135-e137. doi: 10.1111/hae.13087. Epub 2017 Feb 8. No abstract available.

PMID:
28181339
12.

Susceptibility to Miltefosine in Brazilian Clinical Isolates of Leishmania (Viannia) braziliensis.

Espada CR, Ribeiro-Dias F, Dorta ML, Pereira LIA, Carvalho EM, Machado PR, Schriefer A, Yokoyama-Yasunaka JKU, Coelho AC, Uliana SRB.

Am J Trop Med Hyg. 2017 Mar;96(3):656-659. doi: 10.4269/ajtmh.16-0811. Epub 2017 Apr 6.

13.

Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects.

Guimarães LH, Queiroz A, Silva JA, Silva SC, Magalhães V, Lago EL, Machado PR, Bacellar O, Wilson ME, Beverley SM, Carvalho EM, Schriefer A.

PLoS Negl Trop Dis. 2016 Dec 1;10(12):e0005100. doi: 10.1371/journal.pntd.0005100. eCollection 2016 Dec.

14.

Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial.

Prates FV, Dourado ME, Silva SC, Schriefer A, Guimarães LH, Brito MD, Almeida J, Carvalho EM, Machado PR.

Clin Infect Dis. 2017 Jan 1;64(1):67-71. Epub 2016 Nov 1.

PMID:
27803094
15.

The gp63 Gene Cluster Is Highly Polymorphic in Natural Leishmania (Viannia) braziliensis Populations, but Functional Sites Are Conserved.

Medina LS, Souza BA, Queiroz A, Guimarães LH, Lima Machado PR, M Carvalho E, Wilson ME, Schriefer A.

PLoS One. 2016 Sep 20;11(9):e0163284. doi: 10.1371/journal.pone.0163284. eCollection 2016.

16.

Detection of IgG Anti-Leishmania Antigen by Flow Cytometry as a Diagnostic Test for Cutaneous Leishmaniasis.

Pedral-Sampaio G, Alves JS, Schriefer A, Magalhães A, Meyer R, Glesby MJ, Carvalho EM, Carvalho LP.

PLoS One. 2016 Sep 13;11(9):e0162793. doi: 10.1371/journal.pone.0162793. eCollection 2016.

17.

The human platelet alloantigen profile in blood donors from Amazonas, Brazil.

Portela CN, Schriefer A, Albuquerque SR, Perdomo RT, Parente AF, Weber SS.

Transfus Med. 2016 Dec;26(6):448-456. doi: 10.1111/tme.12338. Epub 2016 Aug 16.

PMID:
27527705
18.

Insulin-like growth factor-I serum levels and their biological effects on Leishmania isolates from different clinical forms of American tegumentary leishmaniasis.

de Souza LD, Vendrame CM, de Jesus AR, Carvalho MD, Magalhães AS, Schriefer A, Guimarães LH, Carvalho EM, Goto H.

Parasit Vectors. 2016 Jun 11;9(1):335. doi: 10.1186/s13071-016-1619-x.

19.

Postponing the Hypoglycemic Response to Partial Hepatectomy Delays Mouse Liver Regeneration.

Huang J, Schriefer AE, Cliften PF, Dietzen D, Kulkarni S, Sing S, Monga SP, Rudnick DA.

Am J Pathol. 2016 Mar;186(3):587-99. doi: 10.1016/j.ajpath.2015.10.027. Epub 2016 Jan 6.

20.

Erythema multiforme upon L. braziliensis infection.

Brito G, Dourado M, Schriefer A, Saldanha M, Machado PR.

Eur J Dermatol. 2015 Sep-Oct;25(5):504-5. doi: 10.1684/ejd.2015.2640. No abstract available.

PMID:
26574659
21.

Sustained Presence of Cutaneous Leishmaniasis in Urban Manaus, the Largest Human Settlement in the Amazon.

Benício E, Cordeiro M, Monteiro H, Saboia Moura MA, Oliveira C, Nunes Gadelha EP, Chrusciak-Talhari A, Talhari C, de Lima Ferreira LC, Mira MT, Lima Machado PR, Talhari S, Schriefer A.

Am J Trop Med Hyg. 2015 Dec;93(6):1208-13. doi: 10.4269/ajtmh.14-0164. Epub 2015 Oct 19.

22.

Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology.

Yu J, Cliften PF, Juehne TI, Sinnwell TM, Sawyer CS, Sharma M, Lutz A, Tycksen E, Johnson MR, Minton MR, Klotz ET, Schriefer AE, Yang W, Heinz ME, Crosby SD, Head RD.

BMC Genomics. 2015 Sep 18;16:710. doi: 10.1186/s12864-015-1913-6.

23.

Histologic, Molecular, and Clinical Evaluation of Explanted Breast Prostheses, Capsules, and Acellular Dermal Matrices for Bacteria.

Poppler L, Cohen J, Dolen UC, Schriefer AE, Tenenbaum MM, Deeken C, Chole RA, Myckatyn TM.

Aesthet Surg J. 2015 Aug;35(6):653-68. doi: 10.1093/asj/sjv017.

24.

Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B.

Machado PR, Rosa ME, Guimarães LH, Prates FV, Queiroz A, Schriefer A, Carvalho EM.

Clin Infect Dis. 2015 Sep 15;61(6):945-9. doi: 10.1093/cid/civ416. Epub 2015 Jun 5.

PMID:
26048961
25.

Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.

Huang J, Schriefer AE, Yang W, Cliften PF, Rudnick DA.

Epigenetics. 2014 Nov;9(11):1521-31. doi: 10.4161/15592294.2014.983371.

26.

Forecasting temporal dynamics of cutaneous leishmaniasis in Northeast Brazil.

Lewnard JA, Jirmanus L, Júnior NN, Machado PR, Glesby MJ, Ko AI, Carvalho EM, Schriefer A, Weinberger DM.

PLoS Negl Trop Dis. 2014 Oct 30;8(10):e3283. doi: 10.1371/journal.pntd.0003283. eCollection 2014 Oct.

27.

Protective and pathologic immune responses in human tegumentary leishmaniasis.

Carvalho LP, Passos S, Schriefer A, Carvalho EM.

Front Immunol. 2012 Oct 4;3:301. doi: 10.3389/fimmu.2012.00301. eCollection 2012.

28.

Association between an emerging disseminated form of leishmaniasis and Leishmania (Viannia) braziliensis strain polymorphisms.

Queiroz A, Sousa R, Heine C, Cardoso M, Guimarães LH, Machado PR, Carvalho EM, Riley LW, Wilson ME, Schriefer A.

J Clin Microbiol. 2012 Dec;50(12):4028-34. doi: 10.1128/JCM.02064-12. Epub 2012 Oct 3.

29.

An assessment of the genetic diversity of Leishmania infantum isolates from infected dogs in Brazil.

Batista LF, Segatto M, Guedes CE, Sousa RS, Rodrigues CA, Brazuna JC, Silva JS, Santos SO, Larangeira D, Macedo AM, Schriefer A, Veras PS.

Am J Trop Med Hyg. 2012 May;86(5):799-806. doi: 10.4269/ajtmh.2012.11-0300.

30.

Combining diagnostic procedures for the management of leishmaniasis in areas with high prevalence of Leishmania guyanensis.

Benicio Ede A, Gadelha EP, Talhari A, Silva RM Jr, Ferreira LC, Santos MC, Mira MT, Oliveira CM, Talhari C, Talhari S, Machado PR, Schriefer A.

An Bras Dermatol. 2011 Nov-Dec;86(6):1141-4.

31.

Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples.

Weirather JL, Jeronimo SM, Gautam S, Sundar S, Kang M, Kurtz MA, Haque R, Schriefer A, Talhari S, Carvalho EM, Donelson JE, Wilson ME.

J Clin Microbiol. 2011 Nov;49(11):3892-904. doi: 10.1128/JCM.r00764-11.

32.

Immunoregulatory and Effector Activities in Human Cutaneous and Mucosal Leishmaniasis: Understanding Mechanisms of Pathology.

Dutra WO, de Faria DR, Lima Machado PR, Guimarães LH, Schriefer A, Carvalho E, Gollob KJ.

Drug Dev Res. 2011 Sep;72(6):430-436.

33.

Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response.

Machado PR, Rosa ME, Costa D, Mignac M, Silva JS, Schriefer A, Teixeira MM, Bacellar O, Carvalho EM.

Trans R Soc Trop Med Hyg. 2011 Aug;105(8):438-44. doi: 10.1016/j.trstmh.2011.05.002. Epub 2011 Jul 2.

34.

IL-17 and Regulatory Cytokines (IL-10 and IL-27) in L. braziliensis Infection.

Novoa R, Bacellar O, Nascimento M, Cardoso TM, Ramasawmy R, Oliveira WN, Schriefer A, Carvalho EM.

Parasite Immunol. 2011 Feb;33(2):132-6. doi: 10.1111/j.1365-3024.2010.01256.x.

35.

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.

Machado PR, Ampuero J, Guimarães LH, Villasboas L, Rocha AT, Schriefer A, Sousa RS, Talhari A, Penna G, Carvalho EM.

PLoS Negl Trop Dis. 2010 Dec 21;4(12):e912. doi: 10.1371/journal.pntd.0000912.

36.

Identification and characterization of a class III chitin synthase gene of Moniliophthora perniciosa, the fungus that causes witches' broom disease of cacao.

Souza CS, Oliveira BM, Costa GG, Schriefer A, Selbach-Schnadelbach A, Uetanabaro AP, Pirovani CP, Pereira GA, Taranto AG, Cascardo JC, Góes-Neto A.

J Microbiol. 2009 Aug;47(4):431-40. doi: 10.1007/s12275-008-0166-3. Epub 2009 Sep 9.

PMID:
19763417
37.

Geographic clustering of leishmaniasis in northeastern Brazil.

Schriefer A, Guimarães LH, Machado PR, Lessa M, Lessa HA, Lago E, Ritt G, Góes-Neto A, Schriefer AL, Riley LW, Carvalho EM.

Emerg Infect Dis. 2009 Jun;15(6):871-6. doi: 10.3201/eid1506.080406.

38.

Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil.

Guimarães LH, Machado PR, Lago EL, Morgan DJ, Schriefer A, Bacellar O, Carvalho EM.

Trans R Soc Trop Med Hyg. 2009 Jul;103(7):712-5. doi: 10.1016/j.trstmh.2009.04.019. Epub 2009 May 28.

39.

Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.

Nascimento MC, Primo J, Bittencourt A, Siqueira I, de Fátima Oliveira M, Meyer R, Schriefer A, Santos SB, Carvalho EM.

Clin Exp Immunol. 2009 Jun;156(3):455-62. doi: 10.1111/j.1365-2249.2008.03869.x.

40.

Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil.

Unger A, O'Neal S, Machado PR, Guimarães LH, Morgan DJ, Schriefer A, Bacellar O, Glesby MJ, Carvalho EM.

Am J Trop Med Hyg. 2009 Apr;80(4):574-9.

41.

Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis.

Schriefer A, Wilson ME, Carvalho EM.

Curr Opin Infect Dis. 2008 Oct;21(5):483-8. doi: 10.1097/QCO.0b013e32830d0ee8. Review.

42.

Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production.

Leopoldo PT, Machado PR, Almeida RP, Schriefer A, Giudice A, de Jesus AR, Ho JL, Guimarães LH, Bacellar O, Carvalho EM.

BMC Infect Dis. 2006 Apr 25;6:75.

43.

Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis.

Faria DR, Gollob KJ, Barbosa J Jr, Schriefer A, Machado PR, Lessa H, Carvalho LP, Romano-Silva MA, de Jesus AR, Carvalho EM, Dutra WO.

Infect Immun. 2005 Dec;73(12):7853-9.

44.

Successful treatment of refractory cutaneous leishmaniasis with GM-CSF and antimonials.

Almeida RP, Brito J, Machado PL, DE Jesus AR, Schriefer A, Guimarães LH, Carvalho EM.

Am J Trop Med Hyg. 2005 Jul;73(1):79-81.

PMID:
16014838
45.

Expression of the virulence factor, BfpA, by enteropathogenic Escherichia coli is essential for apoptosis signalling but not for NF-kappaB activation in host cells.

Melo AR, Lasunskaia EB, de Almeida CM, Schriefer A, Kipnis TL, Dias da Silva W.

Scand J Immunol. 2005 Jun;61(6):511-9.

46.

Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma.

Araujo MI, Hoppe B, Medeiros M Jr, Alcântara L, Almeida MC, Schriefer A, Oliveira RR, Kruschewsky R, Figueiredo JP, Cruz AA, Carvalho EM.

J Infect Dis. 2004 Nov 15;190(10):1797-803. Epub 2004 Oct 12.

PMID:
15499536
47.

Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis.

Nascimento AL, Ko AI, Martins EA, Monteiro-Vitorello CB, Ho PL, Haake DA, Verjovski-Almeida S, Hartskeerl RA, Marques MV, Oliveira MC, Menck CF, Leite LC, Carrer H, Coutinho LL, Degrave WM, Dellagostin OA, El-Dorry H, Ferro ES, Ferro MI, Furlan LR, Gamberini M, Giglioti EA, Góes-Neto A, Goldman GH, Goldman MH, Harakava R, Jerônimo SM, Junqueira-de-Azevedo IL, Kimura ET, Kuramae EE, Lemos EG, Lemos MV, Marino CL, Nunes LR, de Oliveira RC, Pereira GG, Reis MS, Schriefer A, Siqueira WJ, Sommer P, Tsai SM, Simpson AJ, Ferro JA, Camargo LE, Kitajima JP, Setubal JC, Van Sluys MA.

J Bacteriol. 2004 Apr;186(7):2164-72.

48.

Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis.

Schriefer A, Schriefer AL, Góes-Neto A, Guimarães LH, Carvalho LP, Almeida RP, Machado PR, Lessa HA, de Jesus AR, Riley LW, Carvalho EM.

Infect Immun. 2004 Jan;72(1):508-14.

49.

Egg yolk anti-BfpA antibodies as a tool for recognizing and identifying enteropathogenic Escherichia coli.

de Almeida CM, Quintana-Flores VM, Medina-Acosta E, Schriefer A, Barral-Netto M, Dias da Silva W.

Scand J Immunol. 2003 Jun;57(6):573-82.

50.

Up-regulation of Th1-type responses in mucosal leishmaniasis patients.

Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro de Jesus A, Dutra WO, Gollob KJ, Carvalho EM.

Infect Immun. 2002 Dec;70(12):6734-40.

Supplemental Content

Loading ...
Support Center